// App-Quantinova.ai

503 : A Pilot Phase 1, Randomized, Double-blind, Two-arm, Parallel Group, Single-dose Study to Evaluate the Safety and Pharmacokinetics of CT-P17 and Humira in Healthy Male Subjects

Researchers

Presenter

  • Daniel Furst

Principal Investigators

  • Malcolm Boyce

  • Frans van den Berg

  • SangJoon Lee

  • SungHyun Kim

  • YunJu Bae

  • GoEun Yang

  • JuHeon Koo

  • EunJin Choi

  • Jonathan Kay

Medical Centers

  • Mount Sinai Hospital, Toronto, ON, Canada

  • University of Southern California, Los Angeles, CA

  • Hammersmith Medicines Research, London, United Kingdom

  • Celltrion Inc., Incheon, Republic of Korea

  • University of Massachusetts Memorial Medical Center and University of Massachusetts Medical School, Worcester, MA

Locations

  • Canada

  • United States

  • United Kingdom

  • Republic of South Korea

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Adalimumab

Outcome

  • N/A

Study Design

  • Randomized

  • Pharmacokinetics

  • Double Blind/Blinded

  • Active Comparator

  • Multiple Arm

  • Parallel Group

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved